IRIS
SORRENTINO, Dario Rosario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.199
EU - Europa 2.347
AS - Asia 1.615
SA - Sud America 219
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 10
Totale 13.409
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.145
SG - Singapore 819
UA - Ucraina 772
CN - Cina 551
DE - Germania 493
FI - Finlandia 315
BR - Brasile 202
SE - Svezia 183
RU - Federazione Russa 166
IE - Irlanda 141
IT - Italia 126
TR - Turchia 93
CA - Canada 47
GB - Regno Unito 44
VN - Vietnam 39
KR - Corea 36
FR - Francia 34
NL - Olanda 25
IN - India 21
HK - Hong Kong 16
IR - Iran 14
BE - Belgio 13
PL - Polonia 11
EU - Europa 10
AR - Argentina 8
AT - Austria 7
TN - Tunisia 6
MX - Messico 5
CH - Svizzera 4
AE - Emirati Arabi Uniti 3
CZ - Repubblica Ceca 3
IQ - Iraq 3
KE - Kenya 3
KG - Kirghizistan 3
PK - Pakistan 3
VE - Venezuela 3
CL - Cile 2
EC - Ecuador 2
EG - Egitto 2
ES - Italia 2
IL - Israele 2
JP - Giappone 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
PT - Portogallo 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
CO - Colombia 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
ID - Indonesia 1
JO - Giordania 1
MK - Macedonia 1
PA - Panama 1
PE - Perù 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TW - Taiwan 1
TZ - Tanzania 1
Totale 13.409
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.394
Fairfield 1.206
Houston 818
Ann Arbor 640
Ashburn 552
Seattle 506
Jacksonville 499
Chandler 496
Wilmington 467
Singapore 459
Dearborn 417
Cambridge 406
Beijing 243
Boardman 186
Munich 176
Princeton 146
Dublin 140
Helsinki 103
Izmir 86
San Diego 69
Roanoke 61
Udine 54
Des Moines 43
Nanjing 39
Hefei 37
Dong Ket 36
Seoul 35
Kunming 30
Ottawa 29
Norwalk 28
Ogden 28
Jinan 24
Guangzhou 19
Hong Kong 16
New York 16
Nanchang 15
Redmond 15
Torre Del Greco 13
Andover 12
Brussels 12
Falls Church 12
Grafing 11
São Paulo 11
Toronto 11
Warsaw 11
Los Angeles 9
Redwood City 9
Rio de Janeiro 8
Turku 8
Fuzhou 7
Phoenix 7
Rosendaal 7
Simi Valley 7
Belo Horizonte 6
Changsha 6
Curitiba 6
Goiânia 6
Jyväskylä 6
Leawood 6
Monmouth Junction 6
Moscow 6
Quzhou 6
Shenyang 6
Shenzhen 6
Washington 6
Chengdu 5
Hebei 5
Maserada Sul Piave 5
Ningbo 5
Nuremberg 5
Wuhan 5
Zhengzhou 5
Agugliano 4
Baotou 4
Brasília 4
Campinas 4
Chongqing 4
Dallas 4
Milan 4
Mumbai 4
Osasco 4
San Mateo 4
Santa Clara 4
Shanghai 4
Trieste 4
Wenzhou 4
Xi'an 4
Augusta 3
Belford Roxo 3
Betim 3
Bishkek 3
Brooklyn 3
Chicago 3
Council Bluffs 3
Fremont 3
Ho Chi Minh City 3
Kish 3
London 3
Montreal 3
Nairobi 3
Totale 9.895
Salva come PNG Salva come JPEG
Nome #
Gastric B-cell clonal expansion and Helicobacter pylori infection in patients with autoimmune diseases and with dyspepsia. A follow-up study. 280
Mechanisms of cellular uptake of free fatty acids 238
Letter: when to withhold anti-TNF agents prior to abdominal surgery in patients with Crohn's disease—the jury might still be out 184
Cavernous transformation of the portal vein associated to multiorgan developmental abnormalities 181
B-cell clonal expansion in gastric biopsies of patients with dyspepsia and autoimmune diseases: effect of H. Pylori eradication. 152
Functional and morphological features of isolated hepatocytes preserved in University of Wisconsin solution. 146
Postoperative recurrence of Crohn's disease: the beginning of the end? 145
"Albumin Receptor" uptake kinetics do not require an intact lobular architecture and are not specific for albumin 144
Hepatocellular fatty acid uptake is mediated by a plasma membrane fatty acid binding protein closely related to mitochondrial glutamic oxaloacetic transaminase. 143
Prevention of postoperative recurrence of Crohn's disease: does the type of surgery matter? 141
Bringing Top-End Endoscopy to Regional Australia: Hurdles and Benefits 139
Anti-TNF's for Postoperative Recurrence in Crohn's Disease: The If's and How's 135
Infliximab for postsurgical endoscopic recurrence of Crohn's disease: no trumpets yet 135
Anti-TNFs for prevention of postoperative recurrence of Crohn's disease: a broken record? 134
Hepatocellular 22Na+ uptake: effect-of-oleate 133
Acute severe colitis: infliximab and/or cyclosporine? 132
Low dose infliximab for prevention of postoperative recurrence of crohn's disease: Long term follow-up and impact of infliximab trough levels and antibodies to infliximab 132
Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease 132
Impact of Diagnostic Delay and Associated Factors on Clinical Outcomes in a U.S. Inflammatory Bowel Disease Cohort 131
Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus 131
At physiologic albumin:oleate concentrations oleate uptake by isolated hepatocytes, adipocytes and cardiac myocytes is a saturable function of unbound oleate concentrations. Uptake kinetics are consistent with the conventional theory 130
B-cell clonality and infection with Helicobacter pylori: implications for development of gastric lymphoma 130
Infliximab in Crohn's disease: a look at the (not so distant) future. 128
The hepatocellular transport of sulfobromophthalein-glutathione by clofibrate treated, perfused rat liver 127
Uptake of oleate by isolated rat adipocytes is mediated by a 40 kDa plasma membrane fatty acid binding protein closely related to that in liver and gut 127
Phenobarbital specifically increases the hepatocellular uptake of sulfobromophthalein-glutathione. 126
Transferrin metabolism in alcoholic liver disease. 125
Oleate uptake by isolated hepatocytes and the perfused rat liver is competitively inhibited by palmitate 125
Ustekinumab as induction and maintenance therapy for ulcerative colitis 125
B cell clonality in gastric lymphoid tissues of patients with Sjogren's syndrome 123
Selective effect of infliximab on the inflammatory component of a colonic stricture in Crohn's disease 123
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease after Ileocolonic Resection 123
Mechanistic aspects of hepatic bilirubin uptake 122
Plasma membrane fatty acid-binding protein and mitochondrial glutamic-oxaloacetic transaminase of rat liver are related 122
Fibrocytes, Inflammation, and Fibrosis in Crohn's Disease: Another Piece of the Puzzle. 121
Bile acid secretion and pool size during phenobarbital-induced hypercholeresis 120
Diagnosis and assessment of Crohn's disease: the present and the future 120
Surgery for Crohn's disease and anti-TNF agents. The changing scenario 120
Sex differences in hepatic fatty acid uptake reflect a greater affinity of the transport system in females 119
Ustekinumab as induction and maintenance therapy for Crohn's disease 118
Isolated Bilateral Gastrocnemius Myositis in Crohn Disease Successfully Treated with Adalimumab 118
The role of magnetic resonance imaging in detecting intestinal fibrosis in Crohn's disease. 117
Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjogren's syndrome 117
Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease 117
Transmembrane TNF-α density, but not soluble TNF-α level, is associated with primary response to infliximab in inflammatory bowel disease 116
Therapeutic Targets in Inflammatory Bowel Disease: Are We Getting the Point Across? 116
An increased Bax/Bcl-2 ratio in circulating inflammatory cells predicts primary response to infliximab in inflammatory bowel disease patients 116
Hepatic disposition of clinically useful 5-nitrofurans 115
Isolation and partial characterization of plasma membrane fatty acid binding proteins from myocardium and adipose tissue and their relationship to analogous proteins in liver and gut 115
Prevention of postoperative recurrence of Crohn's disease by infliximab 115
Unbound ligand drives hepatocyte taurocholate and BSP uptake at physiological albumin concentration 112
Role of biologics and other therapies in stricturing Crohn's disease: what have we learnt so far? 111
The race for mainstream gastrointestinal endoscopy: frontrunners. 110
Internet use among inflammatory bowel disease patients: an Italian multicenter survey. 110
The hepatocellular uptake of free fatty acids is selectively preserved during starvation 109
Characteristics of oleate binding to liver plasma membranes and its uptake by isolated hepatocytes 109
Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn's disease. 109
Adipocyte differentiation of 3T3-L1 cells involves augmented expression of a 43 kDa plasma membrane fatty acid binding protein 108
Quantitation of plasma membrane fatty acid binding protein by enzyme dilution and monoclonal antibody based immunoassay 107
"Cervia II Working Group Report 2006": guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy 107
Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents 107
Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis 106
Medical prevention of postoperative recurrence of Crohn’s Disease: The state of the art 106
Esophageal ulceration due to alendronate 106
Familial hyperbilirubinaemia syndromes: kinetic approaches 104
Organic anion-transporting polypeptides: expression cloning and functional tests 104
Microbial dysbiosis in spouses of ulcerative colitis patients: Any clues to disease pathogenesis? 104
Long-term prevention of postoperative Crohn's disease recurrence with azathioprine: the wolf in the sheep clothing. 103
Small Bowel Inflammation in Crohn's Disease and Other Conditions 102
Heart-touching Chilaiditi's syndrome 101
Clinically Significant Small Bowel Crohn's Disease Might Only be Detected by Capsule Endoscopy 100
Scientific publications in gastroenterology and hepatology in Western Europe, USA and Japan in the years 1992-1996: a global survey 100
Continuous monitoring of the biliary excretion of a pulse of labeled compounds 99
Colonic sarcoidosis, infliximab, and tuberculosis: a cautionary tale 99
Ustekinumab induction and maintenance therapy in refractory Crohn's disease. 99
Helicobacter pylori infection and autoimmune processes: an emerging field of study. 98
Diagnostic and Therapeutic Delays in the Management of Postoperative Crohn's Disease 98
Unexplained Symptoms and Hidden Inflammation in Patients With Crohn's Disease 98
Oleate uptake kinetics in the perfused rat liver are consistent with pseudofacilitation by albumin 97
Gastric B-cell clonal expansion and hepatitis C virus infection: a study in patients with Sjögren’s syndrome. 96
B-cell clonality in gastric mucosa of patients with Sjögren's syndrome and connective tissue diseases: relationship with Helicobacter pylori, EBV and human herpesvirus-6 (HHV-6) infections. 96
Utility of fecal markers to diagnose and monitor inflammatory bowel diseases 96
Characterization of prelymphomatous stages of lymphoproliferation in Sjögren’s syndrome. 96
Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: an expert consensus report. 95
Clinical remission after stopping infliximab in Crohn's disease: is all that glitters true gold? 94
Hepatocellular sulfobromophthalein uptake at physiologic albumin concentrations: Kinetic evidence for a high affinity/low capacity sinusoidal membrane system 94
MRI scoring system including dynamic motility evaluation in assessing the activity of Crohn's disease of the terminal ileum 91
The hepatocellular uptake of bilirubin: current concepts and controversies. 89
B-CELL CLONAL EXPANSION IN GASTRIC BIOPSIES OF PATIENTS WITH DYSPEPSIA AND AUTOIMMUNE-DISEASES - EFFECT OF HELICOBACTER-PYLORI ERADICATION 88
The Coming of Age of Inflammatory Bowel Diseases in Asia 87
Gastric lymphoid follicles: prevalence in patients with dyspepsia and with autoimmune diseases and relationship with Helicobacter pylori infection. Gastroenterology 86
Hepatitis C virus infection and gastric lymphoproliferation in patients with Sjögren's syndrome 86
235) La terapia con Infliximab più Metotrexate a basse dosi nella prevenzione delle recidive post-chirurgiche del Morbo diCrohn 86
Early Diagnosis and Treatment of Postoperative Endoscopic Recurrence of Crohn's Disease: Partial Benefit by Infliximab-A Pilot Study 84
From albumin to the cytoplasm: the hepatic uptake of organic anions 82
Risk of combining immunosuppressive and biological treatments in inflammatory bowel disease 82
Capturing the Biologic Onset of Inflammatory Bowel Diseases: Impact on Translational and Clinical Science 81
Management of post-operative Crohn’s disease in 2017: where do we go from here? 78
Knowledge Gaps in the Management of Postoperative Crohn’s Disease: A US National Survey 77
Therapeutic Drug Monitoring and Clinical Outcomes in Immune Mediated Diseases: The Missing Link 76
Totale 11.587
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.873
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.873
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020217 0 0 0 0 0 0 0 0 0 0 0 217
2020/20211.853 38 247 153 213 67 208 93 206 229 68 204 127
2021/20221.177 49 120 51 85 35 57 73 62 12 201 216 216
2022/20231.193 165 79 14 136 116 368 10 69 163 13 20 40
2023/2024276 51 29 12 2 50 50 4 21 38 2 7 10
2024/20252.049 29 171 81 38 211 183 199 192 289 242 339 75
Totale 13.805